LOC730205 Inhibitors
Wortmannin and Triciribine act on the PI3K/AKT pathway, a critical axis in the regulation of cell growth and survival, which LOC730205 may be part of. Rapamycin's inhibition of mTOR can have wide-ranging effects on cell growth and metabolism, which are likely to intersect with the functions of LOC730205. U0126's blockade of the MEK/ERK pathway and PD0332991's targeting of cyclin-dependent kinases can halt cell proliferation, a process where LOC730205 may be implicated.
Bortezomib disrupts protein degradation machinery, which can lead to an altered protein turnover rate, potentially affecting LOC730205's stability. Cyclopamine's interference with Hedgehog signaling and Ibrutinib's action on Bruton's tyrosine kinase can modify cell communication and immune responses, respectively, both of which may involve LOC730205. Thapsigargin's perturbation of calcium homeostasis can have implications for calcium-dependent signaling in which LOC730205 might play a part. Imatinib's broad-spectrum tyrosine kinase inhibition and Axitinib's vascular endothelial growth factor receptor (VEGFR) inhibition can alter growth factor signaling, affecting cellular processes that LOC730205 may be associated with. ABT-199, by inhibiting BCL-2, can trigger apoptotic pathways that are essential for cell fate decisions, which could be regulated by LOC730205.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A PI3K inhibitor that can suppress the PI3K/AKT pathway, potentially altering cellular growth signals that LOC730205 may be involved in. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can disrupt the mTOR signaling pathway, which may control processes such as cell growth where LOC730205 could play a role. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor that can block the MAPK/ERK pathway, which may affect cell differentiation and proliferation associated with LOC730205 activity. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
An AKT inhibitor that can prevent AKT activation, potentially impacting cell survival pathways that involve LOC730205. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can lead to an accumulation of proteins, possibly affecting the degradation pathway of LOC730205. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $94.00 $208.00 | 19 | |
A Hedgehog signaling pathway inhibitor that can interfere with cell signaling events that LOC730205 might participate in. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $156.00 | 5 | |
A Bruton's tyrosine kinase inhibitor that can disrupt B cell receptor signaling, which may indirectly influence LOC730205's function in immune response. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor that can disrupt calcium homeostasis, potentially affecting calcium-dependent processes in which LOC730205 is involved. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
A cyclin-dependent kinase 4/6 inhibitor that can halt cell cycle progression, possibly influencing LOC730205's role in cell division. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
A tyrosine kinase inhibitor that can inhibit multiple signaling pathways, potentially affecting processes where LOC730205 is involved. | ||||||